Trials / Recruiting
RecruitingNCT05526443
Austrian Registry for Evaluation of Treatment Patterns and Outcome in Patients With Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,500 (estimated)
- Sponsor
- Medical University of Graz · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To systematically collect and analyse real-world data on treatment patterns, clinical outcomes and toxicities among patients with advanced pancreatic ductal adenocarcinoma (PDAC) undergoing systematic treatment in Austria
Detailed description
1500 adult patients with locally advanced inoperable and/or metastasized PDAC undergoing first line chemotherapy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | all approved chemotherapeutic agents from second line | all approved chemotherapeutic agents from second line |
Timeline
- Start date
- 2023-01-13
- Primary completion
- 2027-03-01
- Completion
- 2027-09-01
- First posted
- 2022-09-02
- Last updated
- 2025-11-21
Locations
12 sites across 1 country: Austria
Source: ClinicalTrials.gov record NCT05526443. Inclusion in this directory is not an endorsement.